Blue Spoon Consulting®

A Modern
Strategy Story

Blue Spoon is the global leader in positioning strategy at a system level. When the playbook stops working, Blue Spoon designs the exit.

25+
Years in Health & Strategy
Dozens
Products Positioned & Launched
$4B
Healthcare Portfolio Led

Blue Spoon Consulting® is led by its Founder and Executive Director, John G. Singer, a health industry contextualist who brings a complete vision for market innovation from 25+ years of deep, diverse and unique experience as a practitioner, business manager and senior leader in big technology, digital health, marketing, strategic communications, innovation consulting and industry thought leadership across all dimensions of the global health sector.

Enabling strategic fit to a new era — when every institution is asking what to do after the playbook stops working.

Over the course of his career, John has helped position, launch and market dozens of products, medical devices, pharmaceuticals and new operating models for clients that have included Pfizer, Merck, Johnson & Johnson, Janssen, UCB, Takeda, Gilead Sciences, Roche, Bayer, the Veteran's Health Administration, Blue Cross/Blue Shield and MU Health, among many others. He has supported hedge funds and global investment firms, helping them understand the competitive landscape, pricing dynamics and regulatory overview in the market for health information technologies, and advised the biggest brands in management consulting on strategic innovation.

Thought Leadership

Published Ideas That Shaped the Conversation

Global Business Press

New business thinking in Fortune, MIT Sloan Management Review, the Wall Street Journal, the Journal of Business Strategy, and the Oxford Handbook of Innovation Management.

U.S. Army War College

Insights on the future of strategy and competition were used to position innovation initiatives and capability development for the Department of Defense's Third Offset Strategy.

Global Keynotes and Lectures

Guest speaker on market innovation and ecosystem-centered strategy at Cambridge, NYU Stern, RAND Corporation, HEC Lausanne, McGill, ESCP Europe, Rutgers, and leading health organizations.

When Burning Man Comes to Washington

A Field Manual for Riding Chaos — applying complexity theory and systems thinking to institutional leadership when the playbook stops working.

Career Trajectory

Where the Insight Comes From

Most Recent
Chief Strategy Officer, Healthcare at Cognizant Technology Solutions (NYSE: CTSH). Led industry strategy, mergers and acquisitions, market development, strategic sales and executive engagement for new value propositions and emerging technologies across Cognizant's $4 billion healthcare portfolio.
Prior
Global Head of Health Market Strategy, Innovation and Technology at Wipro (NYSE: WIT). Led strategy, innovation, and technology positioning for a leading global technology services company.
Earlier
U.S. Healthcare Practice Lead at RAPP / Omnicom Group. Led digital strategy and consumer experience design for the launch of Sovaldi, Gilead Sciences' cure for Hepatitis C. Directed patient engagement as a strategic pillar for JNJ Diabetes Solutions. Managed the first e-commerce platform in the pharmaceutical industry.
Investment
Supported hedge funds and global investment firms on competitive landscape analysis, pricing dynamics, and regulatory overview in the market for health information technologies.
Defense
Strategy and competition research adopted by the U.S. Army War College for innovation initiatives and capability development under the Department of Defense's Third Offset Strategy.

Ready for modern strategy.

Reach Out